LISTED medication adherence technology firm MedAdvisor has been recognised as one of Australia's fastest growing companies, with revenue increasing on an average annual rate of 84.8% over the last three years.
The company has been included in the Australian Financial Review "Fast 100 Companies" list released yesterday, coming in 23rd position.
The report said MedAdvisor had revenue of $7.39 million, with a 62-strong employee workforce.
CEO Robert Read said he was "honoured and proud" at the recognition by the AFR.
"MedAdvisor has been at the forefront of the 'Health Tech' disruption of the health services industry in Australia for over five years and is widely recognised as the pioneer and leading consumer medication management platform in the health space," he said.
Since its 2013 inception MedAdvisor has grown to have over one million connected users, and is now utilised by over 55% of Australian community pharmacies.
"Our vision is to become the leading platform for patients to easily connect with pharmacies, GPs and hospitals for health-related products and services," Read said.
The Australian Financial Review Fast 100 Companies list (previously the BRW Fast 100) is now in its 29th year of being the "premier guide to the fastest growing small and medium businesses in Australia".
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Nov 18
